Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-10-02
2007-10-02
Kumar, Shailendra (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S231200, C514S252100, C514S350000, C514S383000, C514S396000, C514S406000, C514S419000, C514S423000, C514S443000, C514S469000, C544S166000, C544S336000, C546S229000, C546S298000, C546S336000, C548S262200, C548S335100, C548S491000, C548S537000, C548S560000, C548S565000, C549S057000, C549S468000
Reexamination Certificate
active
10818755
ABSTRACT:
The present invention is directed to certain hydroxamate derivatives that are useful in the treatment of hepatitis C. These compounds are also inhibitors of histone deacetylase and are therefore useful in the treatment of diseases associated with histone deacetylase activity. Pharmaceutical compositions and processes for preparing these compounds are also disclosed.
REFERENCES:
patent: 5972978 (1999-10-01), Andersen et al.
patent: 6211197 (2001-04-01), Belley et al.
patent: 6960685 (2005-11-01), Watkins et al.
patent: 2004/0053908 (2004-03-01), Funahashi et al.
patent: 2004/0077726 (2004-04-01), Watkins et al.
patent: WO95/05358 (1995-02-01), None
patent: WO 00/20371 (2000-04-01), None
patent: WO01/14331 (2001-03-01), None
patent: WO01/38322 (2001-05-01), None
patent: WO02/26703 (2002-04-01), None
patent: WO02/30879 (2002-04-01), None
patent: WO03/013493 (2003-02-01), None
patent: WO03/070691 (2003-08-01), None
patent: WO2004/013130 (2004-02-01), None
Lavoie, Rico, “Design and Synthesis of a Novel Class of Histone Deacetylase Inhibitors”, Bioorganic & Medicinal Chemistry Letters; vol. 11 (2001) pp. 2847-2850.
Uesato, Shinichi, “Novel Histone Deacetylase Inhibitors:N-Hydroxycarboxamides Possessing a Terminal Bicyclic Aryl Group”, Bioorganic & Medicinal Chemistry Letters; vol. 12 (2002) pp. 1347-1349.
Baskaran Chitra
Buggy Joseph J.
Robinson James
Sendzik Martin
Verner Eric J.
Kumar Shailendra
Pharmacyclics Inc.
Wilson Sonsini Goodrich & Rosati
LandOfFree
Hydroxamates as therapeutic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydroxamates as therapeutic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydroxamates as therapeutic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3901867